Search - inc

 
 
Japan Times
BUSINESS / Companies
Nov 30, 2020

Ant IPO said to face slim chances of getting done next year

Understanding the authorities' thinking and navigating the complex rules — some of which are still subject to change — are the biggest hurdles facing Ant.
Japan Times
WORLD / Science & Health
Nov 29, 2020

COVID-19 drugs from Lilly and Regeneron raise access and timing concerns

Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
WORLD / Science & Health
Nov 29, 2020

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
BUSINESS / Companies
Nov 27, 2020

Route uncertain for Japan's two top airlines as ANA seeks ¥332.1 billion

While there's hope a COVID-19 vaccine will get people back on planes, carriers globally are still expected to lose a combined $157 billion in 2020 and 2021.
Japan Times
WORLD / Science & Health
Nov 27, 2020

AstraZeneca considers extra global vaccine trial as questions mount

Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.
Japan Times
WORLD / Science & Health
Nov 25, 2020

‘We’re drowning’: COVID-19 cases flood hospitals in America’s heartland

After pounding big U.S. cities in the spring, the virus now has engulfed rural and small-town America, seeming to seep into the country's every nook and cranny.
COMMENTARY / World / Geoeconomic Briefing
Nov 24, 2020

Undersea internet cables offer more resilient connection

Japan has a new role to play in helping connect Asia with the rest of the world through a growing network of fiber optics.
Japan Times
COMMENTARY
Nov 22, 2020

Pfizer vaccine's safety milestone is just the beginning

As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
BUSINESS / Companies
Nov 21, 2020

ANA looks to raise ¥200 billion in share offering as early as next week

Japan's ANA Holdings Inc. plans to issue new shares following a board meeting as early as next week, two sources said, a move that would see it raise around ¥200 billion to bolster its balance sheet.
Japan Times
WORLD / Science & Health
Nov 19, 2020

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
BUSINESS
Nov 19, 2020

Boeing Max cleared to fly in U.S. as FAA lifts longest grounding

The U.S. actions set the stage for other regulators to clear the Max, which would allow airlines worldwide to resume passenger service with the plane.
Japan Times
WORLD / Science & Health
Nov 18, 2020

Pfizer reaches safety milestone for COVID-19 vaccine, CEO says

Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020

How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine

Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020

WHO warns against COVID-19 complacency after Moderna vaccine news

'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020

How the Moderna and Pfizer coronavirus vaccines stack up

The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020

Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection

A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
WORLD
Nov 13, 2020

Harvard wins appeal on race but the battle is far from over

Harvard University can continue to consider race in its admissions decisions, after a federal appeals court ruled that it isn’t intentionally discriminating against Asian Americans and the policy doesn’t violate the U.S. Constitution.
Japan Times
BUSINESS / Companies
Nov 13, 2020

Has Disney put the worst of the pandemic behind it?

The firm has seen success with its streaming service, which it says has now signed up 73.7 million subscribers.
Japan Times
WORLD / Science & Health
Nov 12, 2020

Moderna COVID-19 vaccine trial reaches key goal to gauge merit

The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
BUSINESS / Companies
Nov 7, 2020

Apple and Sony both held talks about buying podcaster Wondery

Wondery is one of the largest independent podcasting studios and networks, reaching a monthly audience of more than 8 million people.
Japan Times
WORLD / Politics
Nov 4, 2020

Twitter and Facebook suspend some accounts as U.S. election misinformation spreads online

Twitter Inc. and Facebook Inc. on Tuesday suspended several recently created right-leaning news accounts posting information about voting in the hotly contested U.S. election for violating their policies.

Longform

Dangami House is a 180-year-old former samurai residence of the Kato clan, who ruled over Ozu, Ehime Prefecture, until the Meiji Restoration.
A house, a legacy and the quiet work of restoration in rural Japan